Cure My Disease

Don't miss your cure!

 Log in / Sign up

Gentle back pressure may help obese individuals breathe easier

NCT ID NCT07718178

Disease control Sponsor: Cairo University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 21, 2026 · Last updated Jul 30, 2026 · Updated 3 times

Summary

This study investigates whether a manual therapy called Mulligan thoracic mobilization can improve lung function and chest expansion in men aged 25-35 with central obesity. Participants receive either diet and exercise alone or diet and exercise plus the mobilization technique five times a week for eight weeks. The goal is to see if adding this hands-on approach leads to better breathing, physical capacity, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Mulligan Thoracic Mobilization, a manual therapy technique where a physiotherapist applies gentle pressure to the upper back to improve movement and breathing
What this could lead to
If effective, this technique could offer a simple, drug-free way to improve breathing and quality of life for people with central obesity.
What could go wrong
This is a small, early-stage trial with only 60 participants, so results may not apply to everyone. The technique is manual and depends on the therapist's skill.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

25 to 35 years

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Males aged 25-35 years. * Presence of central obesity, defined as: * Waist circumference ≥102 cm in males. * Waist-hip ratio (WHR) ≥0.90 in males. * BMI from 30-39.9 kg/m². * Willing to comply with conventional physiotherapy (diet and exercise) and mobilization programs. * Medically stable individuals with a restrictive lung pattern (Normal FEV₁/FVC ratio and FVC \< 80% of predicted). * Low level physical activity (using the International Physical Activity Questionnaire-Short Version). * Non-smokers. Exclusion Criteria: * Diagnosed COPD, asthma, or other chronic respiratory diseases. * Recent thoracic spine or rib injury/surgery. * Cardiovascular instability or uncontrolled hypertension. * Contraindications to manual therapy (e.g., osteoporosis, rib fractures, or spinal tumors). * Participation in any structured weight loss program or exercise regimen in the past 6 months. * History of bariatric surgery (e.g., gastric sleeve, gastric bypass). * Use of medications that affect body weight or metabolism (e.g., corticosteroids, antipsychotics, weight loss drugs). * Neurological or musculoskeletal conditions that limit mobility or exercise participation and interfere with gait. * Any acute respiratory infections in the past 6 weeks.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Central obesity are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity, Abdominal restrictive pulmonary disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Central obesity Ventilatory function

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.